{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:11:33Z","timestamp":1762906293721,"version":"3.45.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":213,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["19K07213"],"award-info":[{"award-number":["19K07213"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Reports"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ebr.2021.100474","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T03:47:30Z","timestamp":1628394450000},"page":"100474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Trends in prescription of anti-seizure medicines for Japanese pediatric outpatients during 2013\u20132019"],"prefix":"10.1016","volume":"16","author":[{"given":"Daisuke","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Obara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Kashiwagura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youtaro","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiteru","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebr.2021.100474_b0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ebr.2021.100474_b0010","unstructured":"Ministry of Health, Labour and Welfare. Measures against epilepsy, https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000070789_00008.html [accessed July 8 2021]."},{"key":"10.1016\/j.ebr.2021.100474_b0015","doi-asserted-by":"crossref","unstructured":"Hsia Y, Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Sen F, et al. Comparison of antiepileptic drug prescribing in children in three European countries. Epilepsia. 2010;51:789\u201396. 10.1111\/j.1528-1167.2009.02331.x.","DOI":"10.1111\/j.1528-1167.2009.02331.x"},{"key":"10.1016\/j.ebr.2021.100474_b0020","doi-asserted-by":"crossref","first-page":"106448","DOI":"10.1016\/j.eplepsyres.2020.106448","article-title":"Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018","volume":"167","author":"Yu","year":"2020","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ebr.2021.100474_b0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eplepsyres.2018.07.011","article-title":"Antiepileptic drug prescription in Dutch children from 2006\u20132014 using pharmacy-dispensing data","volume":"146","author":"Weijenberg","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ebr.2021.100474_b0030","unstructured":"World Health Organization. International statistical classification of diseases and related health problems 10th revision, https:\/\/icd.who.int\/browse10\/2019\/en; 2019 [accessed May 9 2021]."},{"key":"10.1016\/j.ebr.2021.100474_b0035","unstructured":"The R Foundation. The R Project for Statistical Computing, https:\/\/www.r-project.org\/; 2021 [accessed May 9 2021]."},{"key":"10.1016\/j.ebr.2021.100474_b0040","unstructured":"National Institute for Health and Care Excellence. Epilepsies: diagnosis and management clinical guideline [CG137], https:\/\/www.nice.org.uk\/guidance\/cg137\/chapter\/1-Guidance; 2012 [accessed 28 April 2021]."},{"key":"10.1016\/j.ebr.2021.100474_b0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/0378-6323.16782","article-title":"Carbamazepine\u2014The commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years","volume":"71","author":"Devi","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.ebr.2021.100474_b0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.seizure.2016.01.017","article-title":"The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population","volume":"36","author":"Tekg\u00fcl","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.ebr.2021.100474_b0055","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","article-title":"Malformation risks of antiepileptic drug monotherapies in pregnancy: Updated results from the UK and Ireland epilepsy and pregnancy registers","volume":"85","author":"Campbell","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ebr.2021.100474_b0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2013.09.007","article-title":"Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010","volume":"23","author":"Pickrell","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.ebr.2021.100474_b0065","unstructured":"Pharmaceuticals and Medical Devices Agency. Compliance with dosage and administration and ensuring early detection for Lamictal tablets (lamotrigine)-induced serious skin disorders, https:\/\/www.pmda.go.jp\/files\/000153788.pdf; 2012 [accessed 20 June 2021]."},{"key":"10.1016\/j.ebr.2021.100474_b0070","unstructured":"Food and Drug Administration. Studies show increased risk of heart rhythm problems with seizure and mental health medicine lamotrigine (Lamictal) in patients with heart disease, https:\/\/www.fda.gov\/media\/147183\/download; 2021 [accessed 20 June 2021]."},{"key":"10.1016\/j.ebr.2021.100474_b0075","unstructured":"Japanese Society of Neurology. Epilepsy practice guidelines 2018, https:\/\/www.neurology-jp.org\/guidelinem\/tenkan_2018.html; 2018 [accessed 21 June 2021]."}],"container-title":["Epilepsy & Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986421000484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986421000484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:07:55Z","timestamp":1762906075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986421000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":15,"alternative-id":["S2589986421000484"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2021.100474","relation":{},"ISSN":["2589-9864"],"issn-type":[{"type":"print","value":"2589-9864"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in prescription of anti-seizure medicines for Japanese pediatric outpatients during 2013\u20132019","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2021.100474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100474"}}